-
Signature
-
/s/ Christopher Krueger, as Attorney-in-Fact
-
Issuer symbol
-
VTYX
-
Transactions as of
-
21 Jan 2024
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
23 Jan 2024, 17:00:43 UTC
Quoteable Key Fact
"Sheila Gujrathi filed Form 4 for Ventyx Biosciences, Inc. (VTYX) on 23 Jan 2024."
Quick Takeaways
- This page summarizes Sheila Gujrathi's Form 4 filing for Ventyx Biosciences, Inc. (VTYX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 23 Jan 2024, 17:00.
What Changed
- Previous filing in this sequence was filed on 16 Jun 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VTYX |
Stock Option (Right to Buy) |
Award |
$0 |
+80,000 |
|
$0.000000 |
80,000 |
21 Jan 2024 |
Common Stock |
80,000 |
$1.97 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: